Andrew Z. Wang
Laboratory of Nano- and Translational Medicine,
Department of Radiation Oncology,
Lineberger Comprehensive Cancer Center,
Laboratory of Nano- and Translational Medicine, Department of Radiation Oncology, Lineberger Comprehensive Cancer Center
University of North Carolina School of Medicine
Andrew Z. Wang has not added Biography.
If you are Andrew Z. Wang and would like to personalize this page please email our Author Liaison for assistance.
Nanotechnology and aptamers: applications in drug delivery.
Trends in biotechnology Aug, 2008 | Pubmed ID: 18571753
Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy.
ChemMedChem Sep, 2008 | Pubmed ID: 18613203
Biofunctionalized targeted nanoparticles for therapeutic applications.
Expert opinion on biological therapy Aug, 2008 | Pubmed ID: 18613759
HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy.
ChemMedChem Dec, 2008 | Pubmed ID: 19012296
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
ACS nano Aug, 2008 | Pubmed ID: 19206374
Improving local control in rectal cancer: radiation sensitizers or radiation dose?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Apr, 2010 | Pubmed ID: 20194836
ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation.
Nanomedicine (London, England) Apr, 2010 | Pubmed ID: 20394530
Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles.
Proceedings of the National Academy of Sciences of the United States of America Jan, 2011 | Pubmed ID: 21220299
Chemoradiation therapy in the management of gastrointestinal malignancies.
Future oncology (London, England) Mar, 2011 | Pubmed ID: 21417904
Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis.
Biomaterials Nov, 2011 | Pubmed ID: 21843904
Nanoparticle delivery of cancer drugs.
Annual review of medicine Feb, 2012 | Pubmed ID: 21888516
Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy.
ACS nano Nov, 2011 | Pubmed ID: 22011071
Preparation of Neutron-Activatable Holmium Nanoparticles for the Treatment of Ovarian Cancer Metastases.
Small (Weinheim an der Bergstrasse, Germany) Feb, 2012 | Pubmed ID: 22298503
Is Primary Prostate Cancer Treatment Influenced by Likelihood of Extraprostatic Disease? A Surveillance, Epidemiology and End Results Patterns of Care Study.
International journal of radiation oncology, biology, physics Jan, 2012 | Pubmed ID: 22300560
